In Vitro Synergy of Pongamia pinnata Extract in Combination with Antibiotics for Inhibiting and Killing

Po-An Su1,2, Shun-Lai Li3, Hung-Jen Tang1

  • 1Department of Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.

Abstract

Insights

Aqueous extracts from Pongamia pinnata seed coats show significant potential as antimicrobial agents. Combining these extracts with antibiotics effectively combats drug-resistant bacteria like MRSA, offering a promising alternative to traditional drug development.

Area of Science:

  • Microbiology
  • Pharmacology
  • Ethnobotany

Background:

  • The rise of multidrug-resistant pathogens presents a critical global health challenge.
  • Developing novel antimicrobial agents is a lengthy and expensive process.
  • Medicinal plants offer a viable alternative for discovering new antibiotics or potentiating existing ones.

Purpose of the Study:

  • To investigate the antibacterial activity of Pongamia pinnata seed coat extracts.
  • To evaluate the synergistic effects of P. pinnata extracts in combination with various antibiotics against MRSA.
  • To explore P. pinnata as a source for novel antimicrobial agents.

Main Methods:

  • Aqueous extracts of P. pinnata seed coat were prepared.
  • Antibacterial activity was assessed using broth dilution, checkerboard, and time-kill assays.
  • Combinations of P. pinnata extracts with antibiotics were tested against methicillin-resistant Staphylococcus aureus (MRSA).

Main Results:

  • Synergistic effects (FIC index < 0.5) were observed in 70%–100% of P. pinnata and antibiotic combinations (ampicillin, meropenem, cefazolin, cefotaxime, cefpirome, cefuroxime).
  • Time-kill assays demonstrated synergistic activity even at low concentrations of P. pinnata, except when combined with aztreonam.
  • No antagonistic interactions were detected between P. pinnata extracts and the tested antibiotics.

Conclusions:

  • Aqueous seed coat extracts of P. pinnata exhibit significant antimicrobial potential.
  • P. pinnata extracts can enhance the efficacy of conventional antibiotics against MRSA.
  • These findings support the development of P. pinnata-derived compounds as novel antimicrobial agents.